Contrast-enhanced power Doppler sonography: Improved detection of characteristic flow patterns in focal liver lesions

Journal of Clinical Ultrasound

Volumn 27, Issue 3, 1999, Pages 107-115

  Hosten, Norbert ^a   Puls, Ralf ^a   Lemke, Arne Jörn ^a   Steger, Wolfgang ^a   Zendel, Wolfgang ^a   Zwicker, Christian ^a   Felix, Roland ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Contrast agent; Focal liver lesions; Power Doppler ultrasonography

Indexed keywords

CONTRAST MEDIUM; SHU 508;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOPPLER FLOWMETRY; HEMANGIOMA; HUMAN; IMAGE ENHANCEMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER INJURY; LIVER METASTASIS;

CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; CONTRAST MEDIA; HEMANGIOMA; HUMANS; HYPERPLASIA; IMAGE ENHANCEMENT; LIVER; LIVER CIRCULATION; LIVER CIRRHOSIS; LIVER NEOPLASMS; POLYSACCHARIDES; REGIONAL BLOOD FLOW; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0033005148     PISSN: 00912751     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0096(199903/04)27:3<107::AID-JCU2>3.0.CO;2-Y     Document Type: Article

References (14)

1. Tanaka S, Kitamura T, Fujita M, et al. Color Doppler flow imaging of liver tumors. AJR Am J Roentgenol 1990;154:509.
2. Nino-Murcia M, Rails PW, Jeffrey RB, et al. Color flow Doppler characterization of focal hepatic lesions. AJR Am J Roentgenol 1992;159:1195.
3. Rubin JM, Bude RO, Carson PL, et al. Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US. Radiology 1994; 190:853.
4. Lencioni R, Pinto F, Armillotta N, et al. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Radiology 1996;201:353.
5. Choi BI, Kim TK, Han JK, et al. Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors. Radiology 1996;200:55.
6. Lee MG, Auh YH, Cho KS, et al. Color Doppler flow imaging of hepatocellular carcinomas: comparison with metastatic tumors and hemangiomas by three-step grading for color hues. Clin Imaging 1996;20:199.
7. Tano S, Ueno N, Tomiyama T. Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced colour Doppler ultrasonography: a preliminary study. Clin Radiol 1997;52:41.
8. Fujimoto M, Moriyasu F, Nishikawa K, et al. Color Doppler sonography of hepatic tumors with galactose-based contrast agent: correlation with angiographic findings. AJR Am J Roentgenol 1994;163: 1099.
9. Ernst H, Hahn EG, Balzer T, et al. Color Doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist. J Clin Ultrasound 1996;24:31.
10. Lin ZY, Wang LY, Wang JH, et al. Clinical utility of color Doppler sonography in the differentiation of hepatocellular carcinoma from metastases and hemangioma. J Ultrasound Med 1997;16:51.
11. Hosoki T, Mitomo M, Choi S, et al. Visualization of tumor vessels in hepatocellular carcinoma. Power Doppler compared with color Doppler and angiography. Acta Radiol 1997;38:422.
12. Wang LY, Wang JH, Lin ZY, et al. Hepatic focal nodular hyperplasia: findings on color Doppler ultrasound. Abdom Imaging 1997;22:178.
13. Numata K, Tanaka K, Kiba T, et al. Use of hepatic tumor index on color Doppler sonography for differentiating large hepatic tumors. AJR Am J Roentgenol 1997;168:991.
14. Uggowitzer M, Kugel C, Machan L, et al. Power Doppler imaging and evaluation of resistive index in focal nodular hyperplasia of the liver. Abdom Imaging 1997;22:268.